| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1225832 | Journal of Proteomics | 2012 | 10 Pages |
Esophageal squamous cell carcinoma (ESCC) is one of the most common primary malignant tumor of digestive tract. However, the early diagnosis and molecular mechanisms that underlie tumor formation and progression have been progressed less. To identify new biomarkers for ESCC, we performed a comparative proteomic research. Isobaric tags for relative and absolute quantitation-based proteomic method was used to screen biomarkers between ESCC and normal. 802 non-redundant proteins were identified, 39 of which were differentially expressed with 1.5-fold difference (29 up-regulated and 10 down-regulated). Through Swiss-Prot and GO database, the location and function of differential proteins were analyzed, which are related to the biological processes of binding, cell structure, signal transduction, cell adhesion, etc. Among the differentially expressed proteins, TP-alpha, collagen alpha-1(VI) chain and S100A9 were verified to be upregulated in 77.19%, 75.44% and 59.65% of ESCC by immunohistochemistry and western-blot. Diagnostic value of these three proteins was validated. These results provide new insights into ESCC biology and potential diagnostic and therapeutic biomarkers, which suggest that TP-alpha, collagen alpha-1(VI) chain and S100A9 are potential biomarkers of ESCC, and may play an important role in tumorigenesis and development of ESCC.
Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (210 K)Download as PowerPoint slideHighlights► A new set of biomarkers for ESCC were explored. ► This study reports iTRAQ-quantification of differential proteins between ESCC and normal. ► Thirty nine of the 802 identified proteins showed to be dysregulated between ESCC and normal. ► TP-alpha, collagen alpha-1(VI) chain and S100A9 were verified as the potential biomarkers of ESCC.
